885-26-7 Usage
General Description
2-PROPOXY-NAPHTHALENE-1-CARBALDEHYDE is a chemical compound that belongs to the class of organic compounds known as benzene and substituted derivatives. It is a colorless to light yellow liquid with a distinct odor. 2-PROPOXY-NAPHTHALENE-1-CARBALDEHYDE is used primarily as a fragrance ingredient in various personal care products and perfumes. It has also been studied for its potential use in chemical synthesis and organic reactions due to its unique structure and reactivity. However, caution should be exercised when handling this compound as it may be harmful if inhaled or ingested, and can cause irritation to the skin and eyes. Therefore, proper safety measures and protective equipment should be used when handling 2-PROPOXY-NAPHTHALENE-1-CARBALDEHYDE.
Check Digit Verification of cas no
The CAS Registry Mumber 885-26-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 8,8 and 5 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 885-26:
(5*8)+(4*8)+(3*5)+(2*2)+(1*6)=97
97 % 10 = 7
So 885-26-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H14O2/c1-2-9-16-14-8-7-11-5-3-4-6-12(11)13(14)10-15/h3-8,10H,2,9H2,1H3
885-26-7Relevant articles and documents
SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS
-
Page column 166, (2010/02/06)
This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therepeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.